Financials
- Market Capitalization 779.14 M
- Employee 61
- Founded 2006
- CEO N/A
- Website www.zevra.com
- Headquarter Delaware, United States
- FIGI BBG0026ZG1F5
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2592 | IVA Inventiva S.A. - American Depository Shares | 4.30 USD | 0.00% | +11.11% | +11.69% | +28.74% | 830.92 M USD | ||
| 2609 | CTMX CytomX Therapeutics, Inc. - Common Stock | 3.70 USD | -1.60% | -3.90% | +21.31% | +56.12% | 805.50 M USD | ||
| 2640 | SPRY ARS Pharmaceuticals, Inc. - Common Stock | 7.74 USD | -2.52% | -8.40% | -21.42% | -15.96% | 768.61 M USD | ||
| 2642 | RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 41.30 USD | -2.94% | +1.57% | +24.25% | +37.07% | 764.14 M USD |
Frequently asked questions about Zevra Therapeutics, Inc. - Common Stock
What is the Zevra Therapeutics, Inc. - Common Stock stock price today?
The current price of Zevra Therapeutics, Inc. - Common Stock (ZVRA) is 13.18. Over the past 24 hours, the stock has changed by -1.27%. Follow the ZVRA chart for real-time price dynamics.
What is the stock ticker of Zevra Therapeutics, Inc. - Common Stock?
Zevra Therapeutics, Inc. - Common Stock trades under the ticker ZVRA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Zevra Therapeutics, Inc. - Common Stock stock going up?
ZVRA has changed by -5.79% over the last week, +2.89% over the last month, and +23.87% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Zevra Therapeutics, Inc. - Common Stock net income for the last quarter?
Zevra Therapeutics, Inc. - Common Stock reported net income of 37.89 M for the last quarter. The previous quarter showed 12.16 M, which means net income changed by +211.47%.
How many employees does Zevra Therapeutics, Inc. - Common Stock have?
As of the latest available data, Zevra Therapeutics, Inc. - Common Stock has 61 employees. Workforce size can provide additional context about the company's scale and operations.
What is Zevra Therapeutics, Inc. - Common Stock EBITDA?
Zevra Therapeutics, Inc. - Common Stock EBITDA is 11.41 M, and its EBITDA margin is 31.51%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Zevra Therapeutics, Inc. - Common Stock stock?
You can buy Zevra Therapeutics, Inc. - Common Stock (ZVRA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Zevra Therapeutics, Inc. - Common Stock stock?
Investing in Zevra Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ZVRA chart and related analysis on metatrader.com as part of your research.